<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38532129</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1432-8798</ISSN><JournalIssue CitedMedium="Internet"><Volume>169</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>27</Day></PubDate></JournalIssue><Title>Archives of virology</Title><ISOAbbreviation>Arch Virol</ISOAbbreviation></Journal><ArticleTitle>Proteomic characteristics of the treatment trajectory of patients with COVID-19.</ArticleTitle><Pagination><StartPage>84</StartPage><MedlinePgn>84</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00705-024-05991-y</ELocationID><Abstract><AbstractText>The ongoing COVID-19 pandemic caused by SARS-CoV-2 has prompted global concern due to its profound impact on public health and the economy. Effective treatment of COVID-19 patients in the acute phase or of those with long COVID is a major challenge. Using data-independent acquisition (DIA) technology, we performed proteomic profiling on plasma samples from 22 COVID-19 patients and six healthy controls at Dazhou Central Hospital. Random&#xa0;forest and least absolute shrinkage and selection operator algorithms were used for analysis at various COVID-19 treatment stages. We identified 79 proteins that were differentially expressed between COVID-19 patients and healthy controls, mainly involving pathways associated with cell processes and binding. Across different treatment stages of COVID-19, five proteins-PI16, GPLD1, IGFBP3, KRT19, and VCAM1-were identified as potential molecular markers for dynamic disease monitoring. Furthermore, the proteins BTD, APOM, IGKV2-28, VWF, C4BPA, and C7 were identified as candidate biomarkers for distinguishing between SARS-CoV-2 positivity and negativity. Analysis of protein change profiles between the follow-up and healthy control groups highlighted cardiovascular changes as a concern for patients recovering from COVID-19. Our study revealed the infection profiles of SARS-CoV-2 at the protein expression level comparing different phases of COVID-19. DIA mass spectrometry analysis of plasma samples from COVID-19 patients undergoing treatment identified key proteins involved in signaling pathways that might be used as markers of the recovery phase. These findings provide insight for the development of therapy options and suggest potential blood biomarkers for COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ding</LastName><ForeName>Guilan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Dazhou Central Hospital, Dazhou, 635000, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Shilin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Dazhou Central Hospital, Dazhou, 635000, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xiangde</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Dazhou Central Hospital, Dazhou, 635000, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Jinliang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Practice, Dazhou Central Hospital, Dazhou, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Sichun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Dazhou Central Hospital, Dazhou, Sichuan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Fanwei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, Sichuan Province Orthopedic Hospital, Chengdu, Sichuan, China. zengfx@pku.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. huangxuan03@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Fanxin</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7337-4463</Identifier><AffiliationInfo><Affiliation>Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan, China. 1244361462@qq.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZDYF0001</GrantID><Agency>Dazhou Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>22ZDYF0020</GrantID><Agency>Dazhou Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>21ZDYF0021</GrantID><Agency>Dazhou Science and Technology Bureau</Agency><Country/></Grant><Grant><GrantID>21CDDZ-26</GrantID><Agency>Dazhou Science and Technology Bureau</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Arch Virol</MedlineTA><NlmUniqueID>7506870</NlmUniqueID><ISSNLinking>0304-8608</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>27</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38532129</ArticleId><ArticleId IdType="doi">10.1007/s00705-024-05991-y</ArticleId><ArticleId IdType="pii">10.1007/s00705-024-05991-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu H, Stratton CW, Tang YW (2020) Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 92:401&#x2013;402. https://doi.org/10.1002/jmv.25678</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25678</ArticleId><ArticleId IdType="pubmed">31950516</ArticleId><ArticleId IdType="pmc">7166628</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DS, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, McHugh TD, Memish ZA, Drosten C, Zumla A, Petersen E (2020) The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health&#x2014;the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 91(2020):264&#x2013;266. https://doi.org/10.1016/j.ijid.2020.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.01.009</ArticleId><ArticleId IdType="pubmed">31953166</ArticleId><ArticleId IdType="pmc">7128332</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipimo PJ, Barradas DT, Kayeyi N, Zulu PM, Muzala K, Mazaba ML, Hamoonga R, Musonda K, Monze M, Kapata N, Sinyange N, Simwaba D, Kapaya F, Mulenga L, Chanda D, Malambo W, Ngosa W, Hines J, Yingst S, Agolory S, Mukonka V (2020) First 100 persons with COVID-19&#x2014;Zambia, March 18&#x2013;April 28, 2020. MMWR Morb Mortal Wkly Rep 69:1547&#x2013;1548. https://doi.org/10.15585/mmwr.mm6942a5</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6942a5</ArticleId><ArticleId IdType="pubmed">33090982</ArticleId><ArticleId IdType="pmc">7583505</ArticleId></ArticleIdList></Reference><Reference><Citation>Klauschen F, Muller KR, Binder A, Bockmayr M, Hagele M, Seegerer P, Wienert S, Pruneri G, de Maria S, Badve S, Michiels S, Nielsen TO, Adams S, Savas P, Symmans F, Willis S, Gruosso T, Park M, Haibe-Kains B, Gallas B, Thompson AM, Cree I, Sotiriou C, Solinas C, Preusser M, Hewitt SM, Rimm D, Viale G, Loi S, Loibl S, Salgado R, Denkert C, G. International Immuno-Oncology Biomarker Working (2018) Scoring of tumor-infiltrating lymphocytes: from visual estimation to machine learning. Semin Cancer Biol 52:151&#x2013;157. https://doi.org/10.1016/j.semcancer.2018.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2018.07.001</ArticleId><ArticleId IdType="pubmed">29990622</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, Liu Y, Xiao J, Liu H, Deng D, Chen S, Zeng W, Feng L, Wu J (2020) Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis 20:559&#x2013;564. https://doi.org/10.1016/S1473-3099(20)30176-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30176-6</ArticleId><ArticleId IdType="pubmed">32220284</ArticleId><ArticleId IdType="pmc">7158904</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetter P, Vu DL, L&#x2019;Huillier AG, Schibler M, Kaiser L, Jacquerioz F (2020) Clinical features of covid-19. BMJ 369:m1470. https://doi.org/10.1136/bmj.m1470</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1470</ArticleId><ArticleId IdType="pubmed">32303495</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo CX, He L, Yin JY, Meng XG, Tan W, Yang GP, Bo T, Liu JP, Lin XJ, Chen X (2020) Epidemiological and clinical features of pediatric COVID-19. BMC Med 18:250. https://doi.org/10.1186/s12916-020-01719-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01719-2</ArticleId><ArticleId IdType="pubmed">32762696</ArticleId><ArticleId IdType="pmc">7408975</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(2020):497&#x2013;506. https://doi.org/10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId><ArticleId IdType="pmc">7159299</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, Dai J, Sun Q, Zhao F, Qu J, Yan F (2020) Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China. J Infect 80:388&#x2013;393. https://doi.org/10.1016/j.jinf.2020.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.02.016</ArticleId><ArticleId IdType="pubmed">32112884</ArticleId><ArticleId IdType="pmc">7102539</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, Kritek PA, West TE, Luks A, Gerbino A, Dale CR, Goldman JD, O&#x2019;Mahony S, Mikacenic C (2020) Covid-19 in critically ill patients in the Seattle Region&#x2014;case series. N Engl J Med 382:2012&#x2013;2022. https://doi.org/10.1056/NEJMoa2004500</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2004500</ArticleId><ArticleId IdType="pubmed">32227758</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z (2020) Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 5:811&#x2013;818. https://doi.org/10.1001/jamacardio.2020.1017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Zhang X, Zhang X, Wei Z, Zhang L, Xu J, Liang P, Xu Y, Zhang C, Xu A (2020) Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16&#x2013;23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact-tracing study. J Infect 80:e1&#x2013;e13. https://doi.org/10.1016/j.jinf.2020.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.006</ArticleId><ArticleId IdType="pubmed">32283156</ArticleId><ArticleId IdType="pmc">7194554</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel R, Babady E, Theel ES, Storch GA, Pinsky BA, St George K, Smith TC, Bertuzzi S (2020) Report from the American Society for Microbiology COVID-19 international summit, 23 March 2020: value of diagnostic testing for SARS-CoV-2/COVID-19. MBio. https://doi.org/10.1128/mBio.00722-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00722-20</ArticleId><ArticleId IdType="pubmed">32546618</ArticleId><ArticleId IdType="pmc">7298708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, Wang X (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581:215&#x2013;220. https://doi.org/10.1038/s41586-020-2180-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Perez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck Jr RW, Hammitt LL, Tureci O, Nell H, Schaefer A, Unal S, Tresnan DB, Mather S, Dormitzer PR, Sahin U, Jansen KU, Gruber WC (2020) C.C.T. Group, safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383:2603&#x2013;2615. https://doi.org/10.1056/NEJMoa2034577</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmith VD, Zhou JJ, Lohmer LRL (2020) The approved dose of Ivermectin alone is not the ideal dose for the treatment of COVID-19. Clin Pharmacol Ther 108:762&#x2013;765. https://doi.org/10.1002/cpt.1889</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1889</ArticleId><ArticleId IdType="pubmed">32378737</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvin MR, Alvarez C, Miller JI, Prates ET, Walker AM, Amos BK, Mast AE, Justice A, Aronow B, Jacobson D (2020) A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife. https://doi.org/10.7554/eLife.59177</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.59177</ArticleId><ArticleId IdType="pubmed">32633718</ArticleId><ArticleId IdType="pmc">7410499</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu T, Ning W, Wu D, Xu J, Han Q, Huang M, Zou X, Yang Q, Yuan Y, Bie Y, Pan S, Mu J, Han Y, Yang X, Zhou H, Li R, Ren Y, Chen X, Yao S, Qiu Y, Zhang DY, Xue Y, Shang Y, Zhou X (2020) Plasma proteomics identify biomarkers and pathogenesis of COVID-19. Immunity 53:1108-1122e1105. https://doi.org/10.1016/j.immuni.2020.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.10.008</ArticleId><ArticleId IdType="pubmed">33128875</ArticleId><ArticleId IdType="pmc">7574896</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B, Yi X, Sun Y, Bi X, Du J, Zhang C, Quan S, Zhang F, Sun R, Qian L, Ge W, Liu W, Liang S, Chen H, Zhang Y, Li J, Xu J, He Z, Chen B, Wang J, Yan H, Zheng Y, Wang D, Zhu J, Kong Z, Kang Z, Liang X, Ding X, Ruan G, Xiang N, Cai X, Gao H, Li L, Li S, Xiao Q, Lu T, Zhu Y, Liu H, Chen H, Guo T (2020) Proteomic and metabolomic characterization of COVID-19 patient Sera. Cell 182:59-72e15. https://doi.org/10.1016/j.cell.2020.05.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId><ArticleId IdType="pmc">7254001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, Peiris M, Poon LLM (2020) Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem 66:549&#x2013;555. https://doi.org/10.1093/clinchem/hvaa029</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/hvaa029</ArticleId><ArticleId IdType="pubmed">32031583</ArticleId><ArticleId IdType="pmc">7108203</ArticleId></ArticleIdList></Reference><Reference><Citation>Echavarria M (2008) Adenoviruses in immunocompromised hosts. Clin Microbiol Rev 21:704&#x2013;715. https://doi.org/10.1128/CMR.00052-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00052-07</ArticleId><ArticleId IdType="pubmed">18854488</ArticleId><ArticleId IdType="pmc">2570151</ArticleId></ArticleIdList></Reference><Reference><Citation>Julkunen I (1984) Serological diagnosis of parainfluenza virus infections by enzyme immunoassay with special emphasis on purity of viral antigens. J Med Virol 14:177&#x2013;187. https://doi.org/10.1002/jmv.1890140212</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.1890140212</ArticleId><ArticleId IdType="pubmed">6092530</ArticleId></ArticleIdList></Reference><Reference><Citation>C. Centers for Disease, Prevention (2006) New laboratory assay for diagnostic testing of avian influenza A/H5 (Asian lineage). MMWR Morb Mortal Wkly Rep 55:127</Citation></Reference><Reference><Citation>Paules C, Subbarao K (2017) Influenza. Lancet 390:697&#x2013;708. https://doi.org/10.1016/S0140-6736(17)30129-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30129-0</ArticleId><ArticleId IdType="pubmed">28302313</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths C, Drews SJ, Marchant DJ (2017) Respiratory syncytial virus: infection, detection, and new options for prevention and treatment. Clin Microbiol Rev 30:277&#x2013;319. https://doi.org/10.1128/CMR.00010-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00010-16</ArticleId><ArticleId IdType="pubmed">27903593</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W, Hao P (2020) Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63:457&#x2013;460. https://doi.org/10.1007/s11427-020-1637-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1637-5</ArticleId><ArticleId IdType="pubmed">32009228</ArticleId><ArticleId IdType="pmc">7089049</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein LR, Zhang L (2020) Gallium maltolate has in vitro antiviral activity against SARS-CoV-2 and is a potential treatment for COVID-19. Antivir Chem Chemother 28:2040206620983780. https://doi.org/10.1177/2040206620983780</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2040206620983780</ArticleId><ArticleId IdType="pubmed">33353394</ArticleId><ArticleId IdType="pmc">7768870</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhogbani T (2016) Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med 36:78&#x2013;80. https://doi.org/10.5144/0256-4947.2016.78</Citation><ArticleIdList><ArticleId IdType="doi">10.5144/0256-4947.2016.78</ArticleId><ArticleId IdType="pubmed">26922692</ArticleId><ArticleId IdType="pmc">6074274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061&#x2013;1069. https://doi.org/10.1001/jama.2020.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId><ArticleId IdType="pmc">7042881</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507&#x2013;513. https://doi.org/10.1016/S0140-6736(20)30211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId><ArticleId IdType="pmc">7135076</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu Y, Li J, Zeng Z, Huang B, Zhao J, Liu Q, Wu H, Fu J, Zhang Y, Zhang Y, Cai J, Zeng F (2020) A novel model based on CXCL8-derived radiomics for prognosis prediction in colorectal cancer. Front Oncol 10:575422. https://doi.org/10.3389/fonc.2020.575422</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.575422</ArticleId><ArticleId IdType="pubmed">33178604</ArticleId><ArticleId IdType="pmc">7592598</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicora G, Vitali F, Dagliati A, Geifman N, Bellazzi R (2020) Integrated multi-omics analyses in oncology: a review of machine learning methods and tools. Front Oncol 10:1030. https://doi.org/10.3389/fonc.2020.01030</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2020.01030</ArticleId><ArticleId IdType="pubmed">32695678</ArticleId><ArticleId IdType="pmc">7338582</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77:683&#x2013;690. https://doi.org/10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Wang Y, Cao ZY, Wang MM, Liu XM, Gao T, Hu QK, Yuan WJ, Lin L (2015) Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction. J Cell Mol Med 19:2728&#x2013;2740. https://doi.org/10.1111/jcmm.12659</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12659</ArticleId><ArticleId IdType="pubmed">26290459</ArticleId><ArticleId IdType="pmc">4687701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Li X, Chen M, Feng Y, Xiong C (2020) The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res 116:1097&#x2013;1100. https://doi.org/10.1093/cvr/cvaa078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa078</ArticleId><ArticleId IdType="pubmed">32227090</ArticleId></ArticleIdList></Reference><Reference><Citation>Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, Penninger JM (2002) Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417:822&#x2013;828. https://doi.org/10.1038/nature00786</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature00786</ArticleId><ArticleId IdType="pubmed">12075344</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>